Evidence map›Paper›PMID 26942287›Full record

ArticleAmerican journal of human genetics2016

Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders.

Holly A F Stessman, Marjolein H Willemsen, Michaela Fenckova, Osnat Penn, Alexander Hoischen, Bo Xiong, Tianyun Wang, Kendra Hoekzema, Laura Vives, Ida Vogel and 41 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Translational pediatrics · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. CRISPR-engineered deletion ofbioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Pangenome discovery of missing autism variants.medRxiv : the preprint server for health sciences · 2025
    Article
  16. Article
  17. Biallelic variants in GTF3C3 result in an autosomal recessive disorder with intellectual disability.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors at 20 institutions in 8 countries.

Holly A F StessmanDepartment of Genome Sciences, University of Washington, Seattle, WA 98105, USA.
Marjolein H WillemsenDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands. Electronic address: marjolein.willemsen@radboudumc.nl.
Michaela FenckovaDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Osnat PennDepartment of Genome Sciences, University of Washington, Seattle, WA 98105, USA.
Alexander HoischenDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Bo XiongDepartment of Genome Sciences, University of Washington, Seattle, WA 98105, USA.
Tianyun WangThe State Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan 410078, China.
Kendra HoekzemaDepartment of Genome Sciences, University of Washington, Seattle, WA 98105, USA.
Laura VivesDepartment of Genome Sciences, University of Washington, Seattle, WA 98105, USA.
Ida VogelDepartment of Clinical Genetics, Aarhus University Hospital, Skejby, 8000 Aarhus, Denmark.
Han G BrunnerDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Department of Clinical Genetics, Maastricht University Medical Center+, 6229 HX Maastricht, the Netherlands.
Ineke van der BurgtDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Charlotte W OckeloenDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Janneke H Schuurs-HoeijmakersDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Jolien S Klein Wassink-RuiterDepartment of Genetics, University of Groningen and University Medical Center Groningen, 9700 RB Groningen, the Netherlands.
Connie StumpelDepartment of Clinical Genetics, Maastricht University Medical Center+, 6229 HX Maastricht, the Netherlands.
Servi J C StevensDepartment of Clinical Genetics, Maastricht University Medical Center+, 6229 HX Maastricht, the Netherlands.
Hans S VlesDepartment of Neurologie, Maastricht University Medical Center+, 6229 HX Maastricht, the Netherlands.
Carlo M MarcelisDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Hans van BokhovenDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Vincent CantagrelINSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Imagine Institute, 75015 Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, 75015 Paris, France.
Laurence ColleauxINSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Imagine Institute, 75015 Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, 75015 Paris, France.
Michael NicouleauINSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Imagine Institute, 75015 Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, 75015 Paris, France.
Stanislas LyonnetINSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Imagine Institute, 75015 Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, 75015 Paris, France; Departments of Genetics, Hôpital Necker - Enfants Malades, Assistance Publique - Hôpitaux de Paris, 75015 Paris, France.
Raphael A BernierDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98105, USA.
Jennifer GerdtsDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98105, USA.
Bradley P CoeDepartment of Genome Sciences, University of Washington, Seattle, WA 98105, USA.
Corrado RomanoPediatrics & Medical Genetics, Istituto di Ricovero e Cura a Carattere Scientifico Associazione Oasi Maria Santissima, 94018 Troina, Italy.
Antonino AlbertiPediatrics & Medical Genetics, Istituto di Ricovero e Cura a Carattere Scientifico Associazione Oasi Maria Santissima, 94018 Troina, Italy.
Lucia GrilloLaboratory of Medical Genetics, Istituto di Ricovero e Cura a Carattere Scientifico Associazione Oasi Maria Santissima, 94018 Troina, Italy.
Carmela ScuderiNeuromuscular Diseases Unit, Istituto di Ricovero e Cura a Carattere Scientifico Associazione Oasi Maria Santissima, 94018 Troina, Italy.
Magnus NordenskjöldDepartment of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Solna, Sweden.
Malin KvarnungDepartment of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Solna, Sweden.
Hui GuoThe State Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan 410078, China.
Kun XiaThe State Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan 410078, China.
Amélie PitonDepartment of Translational Medicine and Neurogenetics, Institut Génétique Biologie Moléculaire Cellulaire, 67400 Illkirch, France; Laboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Bénédicte GerardLaboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
David GenevieveDépartement de Génétique Médicale, Centre de Référence Maladies Rares Anomalies du Développement et Syndromes Malformatifs Sud-Languedoc Roussillon, Hôpital Arnaud de Villeneuve, 34090 Montpellier, France.
Bruno DelobelCentre de Génétique Chromosomique, Hôpital Saint Vincent de Paul, Groupement des Hôpitaux de l'Institut Catholique de Lille, 59000 Lille, France.
Daphne LehalleÉquipe EA4271-GAD, Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, Fédération Hospitalo-Universitaire TRANSLAD, 21079 Dijon, France.
Laurence PerrinService de Génétique Clinique, Hôpital Robert Debré, 75019 Paris, France.
Fabienne PrieurService de Génétique Clinique Chromosomique et Moléculaire, Centre Hospitalier Universitaire de Saint-Étienne, 42100 Saint-Étienne, France.
Julien ThevenonÉquipe EA4271-GAD, Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, Fédération Hospitalo-Universitaire TRANSLAD, 21079 Dijon, France.
Jozef GeczRobinson Research Institute, University of Adelaide and Women's and Children's Hospital, North Adelaide SA 5006, Australia.
Marie ShawRobinson Research Institute, University of Adelaide and Women's and Children's Hospital, North Adelaide SA 5006, Australia.
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Boris KerenDépartement de Génétique, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75013 Paris, France; INSERM UM75 and U1127, CNRS UMR7225, Université Pierre et Marie Curie (Paris 6) and Institut du Cerveau et de la Moelle épinière, 75013 Paris, France.
Aurelia JacquetteDépartement de Génétique, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, 75013 Paris, France.
Annette SchenckDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Evan E EichlerDepartment of Genome Sciences, University of Washington, Seattle, WA 98105, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA. Electronic address: eee@gs.washington.edu.
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
University of Washington · USRadboud University Medical Center · NLRadboud University Nijmegen · NLMaastricht University · NLOasi Maria SS · ITCentral South University · CNHôpitaux Universitaires de Strasbourg · FRInstitut des Maladies Génétiques Imagine · FRKarolinska Institutet · SEWomen's and Children's Hospital · AUAarhus University Hospital · DKCentre Hospitalier Universitaire de Saint-Étienne · FRCentre Hospitalier Universitaire Dijon Bourgogne · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRFédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine · FRHôpital Arnaud de Villeneuve · FRHôpital Robert-Debré · FRHôpital Saint-Vincent-de-Paul · FRPitié-Salpêtrière Hospital · FR

Funding

INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI DOHERTY, DANIEL · 2014 to 2019
$7.9M
Phenotypic Characterization of Gene Disrupting Mutations in ASDR01MH100047 · NIMH · UNIVERSITY OF WASHINGTON · PI BERNIER, RAPHAEL A · 2014 to 2018
$2.1M
NHGRI NIH HHS T32 HG000035NICHD NIH HHS U54 HD083091NIMH NIH HHS R01 MH100047NIMH NIH HHS R01 MH101221
6 · The paper itself

Abstract

Intellectual disability (ID) and autism spectrum disorders (ASD) are genetically heterogeneous, and a significant number of genes have been associated with both conditions. A few mutations in POGZ have been reported in recent exome studies; however, these studies do not provide detailed clinical information. We collected the clinical and molecular data of 25 individuals with disruptive mutations in POGZ by diagnostic whole-exome, whole-genome, or targeted sequencing of 5,223 individuals with neurodevelopmental disorders (ID primarily) or by targeted resequencing of this locus in 12,041 individuals with ASD and/or ID. The rarity of disruptive mutations among unaffected individuals (2/49,401) highlights the significance (p = 4.19 × 10(-13); odds ratio = 35.8) and penetrance (65.9%) of this genetic subtype with respect to ASD and ID. By studying the entire cohort, we defined common phenotypic features of POGZ individuals, including variable levels of developmental delay (DD) and more severe speech and language delay in comparison to the severity of motor delay and coordination issues. We also identified significant associations with vision problems, microcephaly, hyperactivity, a tendency to obesity, and feeding difficulties. Some features might be explained by the high expression of POGZ, particularly in the cerebellum and pituitary, early in fetal brain development. We conducted parallel studies in Drosophila by inducing conditional knockdown of the POGZ ortholog row, further confirming that dosage of POGZ, specifically in neurons, is essential for normal learning in a habituation paradigm. Combined, the data underscore the pathogenicity of loss-of-function mutations in POGZ and define a POGZ-related phenotype enriched in specific features.

Indexed as

AdolescentAdultAnimalsAutism Spectrum DisorderCell Cycle ProteinsChildChild, PreschoolCohort StudiesDNA-Binding ProteinsDown-RegulationDrosophilaDrosophila ProteinsExomeFemaleGene Knockdown TechniquesGenome-Wide Association StudyCell Cycle ProteinsDNA-Binding ProteinsDrosophila ProteinsPOGZ protein, humanROW protein, DrosophilaTranscription FactorsTransposases

Identifiers

PMID26942287
PMCPMC4890241
OpenAlexW2291183135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.